HGH 191aa is growth hormone itself. That single fact separates it from almost every other compound in the Growth & Performance category, and it is the most common point of confusion on any vendor menu. Sermorelin, CJC-1295, tesamorelin and ipamorelin are secretagogues — molecules that signal the pituitary to release the body's own growth hormone. HGH 191aa skips the pituitary entirely and supplies the hormone directly.
Structurally it is a 191-amino-acid single-chain polypeptide registered under CAS 12629-01-5, molecular formula C990H1528N262O300S7, molecular weight 22,124 g/mol. The "191aa" in the name is doing real work: it signals the full-length sequence, identical in length to pituitary-derived growth hormone, as distinct from truncated forms such as AOD-9604, which is a fragment of residues 176–191 of that same sequence.
It is produced by recombinant expression rather than extracted from tissue, and supplied as a lyophilized powder for laboratory reconstitution. In research settings it serves as a reference standard for growth hormone receptor work — the known quantity an assay is calibrated against.
On the purity figure. ZestyRat publishes 96%+ HPLC for this product, and at a glance that reads weaker than the 99%+ posted on short synthetic peptides. It is not, and the reason is analytical rather than promotional. A 191-residue recombinant protein is a fundamentally harder target than a 5mg synthetic like BPC-157: longer chains carry more opportunity for deamidation, oxidation and conformational variants, and recombinant expression introduces host-cell considerations that solid-phase synthesis does not. A 96% figure on a 22 kDa protein and a 99% figure on a 15-residue peptide are not the same measurement.
Storage carries the same asymmetry. As lyophilized powder the material is specified for -20°C, protected from light and moisture. Recombinant proteins are more sensitive to freeze-thaw cycling and to heat in transit than small synthetics, which makes a supplier's shipping practice a genuine quality variable here rather than a footnote — and is one reason we weight same-day dispatch and tracking as heavily as we do.
Summary of published preclinical and clinical literature and supplier-published specifications, provided for research context only. Not a claim of efficacy and not medical advice.
